[Tamoxifen and cervico-vaginal cytology].
The impact of tamoxifen on the genital tract was assessed by cervico-vaginal cytology. Fifty two post-menopausal patients treated with tamoxifen for breast cancer were regularly monitored, with a pre-treatment reference smear showing a profoundly menopausal status, followed by an anual smear. Smears returned to a functional status in 44% of patients after 2 to 5 years treatment. The agonist effect of tamoxifen appears to be beyond any doubt, and responsible for certain adverse reactions. This should not bring into question the usefulness of the drug, but indicates the need for regular monitoring and, in the presence of a functional smear, further investigation by vaginal ultrasonography is essential in order to evaluate the status of the endometrium.
Service de Gynécologie-Obstétrique, CHU La Grave, Toulouse.
J M
JM
Ayoubi
X
X
Monrozies
F
F
Ayoubi
T
T
Charasson
J M
JM
Reme
D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy*; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D006801:Humans; D008875:Middle Aged; D017698:Postmenopause / Q000187:drug effects*; D013629:Tamoxifen / Q000627:therapeutic use*; D013997:Time Factors; D014626:Vaginal Smears
D013629:Tamoxifen
Tamoxifène et frottis cervico-vaginal.